Genetic variability at IMPA2, INPP1 and GSK3β increases the risk of suicidal behavior in bipolar patients

European Neuropsychopharmacology

Volumn 23, Issue 11, 2013, Pages 1452-1462

  Jimenez E ^a   Arias, B ^b   Mitjans, M ^b   Goikolea, J M ^a   Roda, E ^c   Saiz P A ^d   Garcia Portilla M P ^d   Buron P ^d   Bobes, J ^d   Oquendo, M A ^e   Vieta, E ^a   Benabarre, A ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d UNIVERSIDAD DE OVIEDO   (Spain)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Bipolar disorder; GSK3 ; IMPA2; INPP1; Lithium; Suicidal behavior

Indexed keywords

BETA CATENIN; INOSITOL PHOSPHATE; WNT PROTEIN;

ADULT; ALLELE; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GSK3BETA GENE; HAPLOTYPE; HIGH RISK PATIENT; HUMAN; IMPA2 GENE; INPP1 GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT;

BIPOLAR DISORDER; GSK3Β; IMPA2; INPP1; LITHIUM; SUICIDAL BEHAVIOR;

ALLELES; BIPOLAR DISORDER; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLYCOGEN SYNTHASE KINASE 3; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; PHOSPHORIC MONOESTER HYDROLASES; POLYMORPHISM, SINGLE NUCLEOTIDE; SUICIDE, ATTEMPTED;

EID: 84886793383     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2013.01.007     Document Type: Article

References (92)

1. Abreu L.N., Lafer B., Baca-Garcia E., Oquendo M.A. Suicidal ideation and suicide attempts in bipolar disorder type I: an update for the clinician. Rev. Bras. Psiquiatr. 2009, 31:271-280.
2. Azorin J.M., Kaladjian A., Adida M., Hantouche E., Hameg A., Lancrenon S., Akiskal H.S. Risk factors associated with lifetime suicide attempts in bipolar I patients: findings from a French National Cohort. Compr. Psychiatry. 2009, 50:115-120.
3. Baldessarini R.J., Pompili M., Tondo L. Suicide in bipolar disorder: risks and management. CNS Spectr. 2006, 11:465-471.
4. Baldessarini R.J., Tondo L., Davis P., Pompili M., Goodwin F.K., Hennen J. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord. 2006, 8:625-639.
5. Baralle D., Baralle M. Splicing in action: assessing disease causing sequence changes. J. Med. Genet. 2005, 42:737-748.
6. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
7. Beck A.T., Steer R.A., Ranieri W.F. Scale for Suicide Ideation: psychometric properties of a self-report version. J. Clin. Psychol. 1988, 44:499-505.
8. Brent D.A., Oquendo M., Birmaher B., Greenhill L., Kolko D., Stanley B., Zelazny J., Brodsky B., Bridge J., Ellis S., Salazar J.O., Mann J.J. Familial pathways to early-onset suicide attempt: risk for suicidal behavior in offspring of mood-disordered suicide attempters. Arch. Gen. Psychiatry 2002, 59:801-807.
9. Carballo J.J., Akamnonu C.P., Oquendo M.A. Neurobiology of suicidal behavior. An integration of biological and clinical findings. Arch. Suicide Res. 2008, 12:93-110.
10. Chaudhury S.R., Grunebaum M.F., Galfalvy H.C., Burke A.K., Sher L., Parsey R.V., Everett B., Mann J.J., Oquendo M.A. Does first episode polarity predict risk for suicide attempt in bipolar disorder?. J. Affect. Disord. 2007, 104:245-250.
11. Chen Y.W., Dilsaver S.C. Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other Axis I disorders. Biol. Psychiatry 1996, 39:896-899.
12. Cipriani A., Pretty H., Hawton K., Geddes J.R. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am. J. Psychiatry 2005, 162:1805-1819.
13. Colom F., Vieta E., Daban C., Pacchiarotti I., Sanchez-Moreno J. Clinical and therapeutic implications of predominant polarity in bipolar disorder. J. Affect. Disord. 2006, 93:13-17.
14. Colom F., Vieta E., Martinez-Aran A., Garcia-Garcia M., Reinares M., Torrent C., Goikolea J.M., Banus S., Salamero M. [Spanish version of a scale for the assessment of mania: validity and reliability of the Young Mania Rating Scale]. Med. Clin. (Barc.) 2002, 119:366-371.
15. Correa H., Campi-Azevedo A.C., De M.L., Boson W., Viana M.M., Guimaraes M.M., Costa E., Miranda D.M., Romano-Silva M.A. Familial suicide behaviour: association with probands suicide attempt characteristics and 5-HTTLPR polymorphism. Acta Psychiatr. Scand. 2004, 110:459-464.
16. Cruz N., Vieta E., Comes M., Haro J.M., Reed C., Bertsch J. Rapid-cycling bipolar I disorder: course and treatment outcome of a large sample across Europe. J. Psychiatr. Res. 2008, 42:1068-1075.
17. Daban C., Colom F., Sanchez-Moreno J., Garcia-Amador M., Vieta E. Clinical correlates of first-episode polarity in bipolar disorder. Compr. Psychiatry 2006, 47:433-437.
18. Dalton E.J., Cate-Carter T.D., Mundo E., Parikh S.V., Kennedy J.L. Suicide risk in bipolar patients: the role of co-morbid substance use disorders. Bipolar Disord. 2003, 5:58-61.
19. Dimitrova A., Milanova V., Krastev S., Nikolov I., Toncheva D., Owen M.J., Kirov G. Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment. Pharmacogenomics J. 2005, 5:35-41.
20. Dwivedi Y. Brain-derived neurotrophic factor and suicide pathogenesis. Ann. Med. 2010, 42:87-96.
21. Ernst C., Mechawar N., Turecki G. Suicide neurobiology. Prog. Neurobiol. 2009, 89:315-333.
22. Garcia-Amador M., Colom F., Valenti M., Horga G., Vieta E. Suicide risk in rapid cycling bipolar patients. J. Affect. Disord. 2009, 117:74-78.
23. Gonda X., Pompili M., Serafini G., Montebovi F., Campi S., Dome P., Duleba T., Girardi P., Rihmer Z. Suicidal behavior in bipolar disorder: epidemiology, characteristics and major risk factors. J. Affect. Disord. 2012, 143:16-26.
24. Gonzalez-Pinto A., Aldama A., Gonzalez C., Mosquera F., Arrasate M., Vieta E. Predictors of suicide in first-episode affective and nonaffective psychotic inpatients: five-year follow-up of patients from a catchment area in Vitoria, Spain. J. Clin. Psychiatry 2007, 68:242-247.
25. Gonzalez-Pinto A., Mosquera F., Alonso M., Lopez P., Ramirez F., Vieta E., Baldessarini R.J. Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord. 2006, 8:618-624.
26. Goodwin F.K., Jamison K.R. Manic-Depressive Illness 1990, Oxford University Press, New York.
27. Gross-Isseroff R., Biegon A., Voet H., Weizman A. The suicide brain: a review of postmortem receptor/transporter binding studies. Neurosci. Biobehav. Rev. 1998, 22:653-661.
28. Guillaume S., Jaussent I., Jollant F., Rihmer Z., Malafosse A., Courtet P. Suicide attempt characteristics may orientate toward a bipolar disorder in attempters with recurrent depression. J. Affect. Disord. 2010, 122:53-59.
29. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-62.
30. Hawton K., Sutton L., Haw C., Sinclair J., Harriss L. Suicide and attempted suicide in bipolar disorder: a systematic review of risk factors. J. Clin. Psychiatry 2005, 66:693-704.
31. Kalkman H.O. Circumstantial evidence for a role of glutamine-synthetase in suicide. Med. Hypotheses 2011, 76:905-907.
32. Karege F., Perroud N., Burkhardt S., Schwald M., Ballmann E., La H.R., Malafosse A. Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims. Biol. Psychiatry 2007, 61:240-245.
33. Kieseppa T., Partonen T., Haukka J., Kaprio J., Lonnqvist J. High concordance of bipolar I disorder in a nationwide sample of twins. Am. J. Psychiatry 2004, 161:1814-1821.
34. Kim B., Kim C.Y., Hong J.P., Kim S.Y., Lee C., Joo Y.H. Brain-derived neurotrophic factor Val/Met polymorphism and bipolar disorder. Association of the Met allele with suicidal behavior of bipolar patients. Neuropsychobiology 2008, 58:97-103.
35. Kim C.D., Seguin M., Therrien N., Riopel G., Chawky N., Lesage A.D., Turecki G. Familial aggregation of suicidal behavior: a family study of male suicide completers from the general population. Am. J. Psychiatry 2005, 162:1017-1019.
36. Kim S., Choi K.H., Baykiz A.F., Gershenfeld H.K. Suicide candidate genes associated with bipolar disorder and schizophrenia: an exploratory gene expression profiling analysis of post-mortem prefrontal cortex. BMC Genomics 2007, 8:413.
37. Klempan T.A., Sequeira A., Canetti L., Lalovic A., Ernst C., Ffrench-Mullen J., Turecki G. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol. Psychiatry 2009, 14:175-189.
38. Leverich G.S., Altshuler L.L., Frye M.A., Suppes T., Keck P.E., McElroy S.L., Denicoff K.D., Obrocea G., Nolen W.A., Kupka R., Walden J., Grunze H., Perez S., Luckenbaugh D.A., Post R.M. Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. J. Clin. Psychiatry 2003, 64:506-515.
39. Lopez P., Mosquera F., De L.J., Gutierrez M., Ezcurra J., Ramirez F., Gonzalez-Pinto A. Suicide attempts in bipolar patients. J. Clin. Psychiatry 2001, 62:963-966.
40. Malloy-Diniz L.F., Neves F.S., de Moraes P.H., De Marco L.A., Romano-Silva M.A., Krebs M.O., Correa H. The 5-HTTLPR polymorphism, impulsivity and suicide behavior in euthymic bipolar patients. J. Affect. Disord. 2011, 133:221-226.
41. McGuffin P., Perroud N., Uher R., Butler A., Aitchison K.J., Craig I., Lewis C., Farmer A. The genetics of affective disorder and suicide. Eur. Psychiatry 2010, 25:275-277.
42. Merikangas K.R., Jin R., He J.P., Kessler R.C., Lee S., Sampson N.A., Viana M.C., Andrade L.H., Hu C., Karam E.G., Ladea M., Medina-Mora M.E., Ono Y., Posada-Villa J., Sagar R., Wells J.E., Zarkov Z. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch. Gen. Psychiatry 2011, 68:241-251.
43. Michelon L., Meira-Lima I., Cordeiro Q., Miguita K., Breen G., Collier D., Vallada H. Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder. Neurosci. Lett. 2006, 403:288-293.
44. Neves F.S., Malloy-Diniz L., Romano-Silva M.A., Campos S.B., Miranda D.M., De M.L., Figueira P.G., Krebs M.O., Correa H. The role of BDNF genetic polymorphisms in bipolar disorder with psychiatric comorbidities. J. Affect. Disord. 2011, 131:307-311.
45. Neves F.S., Malloy-Diniz L.F., Romano-Silva M.A., Aguiar G.C., de Matos L.O., Correa H. Is the serotonin transporter polymorphism (5-HTTLPR) a potential marker for suicidal behavior in bipolar disorder patients?. J. Affect. Disord. 2010, 125:98-102.
46. Neves F.S., Silveira G., Romano-Silva M.A., Malloy-Diniz L., Ferreira A.A., De M.L., Correa H. Is the 5-HTTLPR polymorphism associated with bipolar disorder or with suicidal behavior of bipolar disorder patients?. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B:114-116.
47. Nivoli A.M., Murru A., Vieta E. Lithium: still a cornerstone in the long-term treatment in bipolar disorder?. Neuropsychobiology 2010, 62:27-35.
48. Nivoli A.M., Pacchiarotti I., Rosa A.R., Popovic D., Murru A., Valenti M., Bonnin C.M., Grande I., Sanchez-Moreno J., Vieta E., Colom F. Gender differences in a cohort study of 604 bipolar patients: the role of predominant polarity. J. Affect. Disord. 2011, 133:443-449.
49. Ohnishi T., Yamada K., Ohba H., Iwayama Y., Toyota T., Hattori E., Inada T., Kunugi H., Tatsumi M., Ozaki N., Iwata N., Sakamoto K., Iijima Y., Iwata Y., Tsuchiya K.J., Sugihara G., Nanko S., Osumi N., Detera-Wadleigh S.D., Kato T., Yoshikawa T. A promoter haplotype of the Inositol Monophosphatase 2 Gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription. Neuropsychopharmacology 2007, 32:1727-1737.
50. Olivier M. From SNPs to function: the effect of sequence variation on gene expression. Focus on "a survey of genetic and epigenetic variation affecting human gene expression". Physiol. Genomics 2004, 16:182-183.
51. Oquendo M.A., Galfalvy H., Russo S., Ellis S.P., Grunebaum M.F., Burke A., Mann J.J. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am. J. Psychiatry 2004, 161:1433-1441.
52. Oquendo M.A., Waternaux C., Brodsky B., Parsons B., Haas G.L., Malone K.M., Mann J.J. Suicidal behavior in bipolar mood disorder: clinical characteristics of attempters and nonattempters. J. Affect. Disord. 2000, 59:107-117.
53. Pacchiarotti I., Mazzarini L., Kotzalidis G.D., Valenti M., Nivoli A.M., Sani G., Torrent C., Murru A., Sanchez-Moreno J., Patrizi B., Girardi P., Vieta E., Colom F. Mania and depression. Mixed, not stirred. J. Affect. Disord. 2011, 133:105-113.
54. Pacchiarotti I., Valenti M., Colom F., Rosa A.R., Nivoli A.M., Murru A., Sanchez-Moreno J., Vieta E. Differential outcome of bipolar patients receiving antidepressant monotherapy versus combination with an antimanic drug. J. Affect. Disord. 2011, 129:321-326.
55. Pacheco M.A., Stockmeier C., Meltzer H.Y., Overholser J.C., Dilley G.E., Jope R.S. Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Res. 1996, 723:37-45.
56. Pandey G.N., Dwivedi Y. What can post-mortem studies tell us about the pathoetiology of suicide?. Future Neurol. 2010, 5:701-720.
57. Perlis R.H., Huang J., Purcell S., Fava M., Rush A.J., Sullivan P.F., Hamilton S.P., McMahon F.J., Schulze T.G., Potash J.B., Zandi P.P., Willour V.L., Penninx B.W., Boomsma D.I., Vogelzangs N., Middeldorp C.M., Rietschel M., Nothen M., Cichon S., Gurling H., Bass N., McQuillin A., Hamshere M., Craddock N., Sklar P., Smoller J.W. Genome-wide association study of suicide attempts in mood disorder patients. Am. J. Psychiatry 2010, 167:1499-1507.
58. Perlis R.H., Miyahara S., Marangell L.B., Wisniewski S.R., Ostacher M., Delbello M.P., Bowden C.L., Sachs G.S., Nierenberg A.A. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol. Psychiatry 2004, 55:875-881.
59. Piccardi M.P., Ardau R., Chillotti C., Deleuze J.F., Mallet J., Meloni R., Oi A., Severino G., Congiu D., Bayorek M., Del Z.M. Manic-depressive illness: an association study with the inositol polyphosphate 1-phosphatase and serotonin transporter genes. Psychiatr. Genet. 2002, 12:23-27.
60. Pompili M., Rihmer Z., Akiskal H.S., Innamorati M., Iliceto P., Akiskal K.K., Lester D., Narciso V., Ferracuti S., Tatarelli R., De P.E., Girardi P. Temperament and personality dimensions in suicidal and nonsuicidal psychiatric inpatients. Psychopathology 2008, 41:313-321.
61. Pompili M., Rihmer Z., Innamorati M., Lester D., Girardi P., Tatarelli R. Assessment and treatment of suicide risk in bipolar disorders. Expert Rev. Neurother. 2009, 9:109-136.
62. Quiroz J.A., Gould T.D., Manji H.K. Molecular effects of lithium. Mol. Interv. 2004, 4:259-272.
63. R Development Core Team, 2008. R: A Language and Environment for Statistical Computing. Vienna, Austria, R Foundation for Statistical Computing. Ref Type: Computer Program.
64. Ramos-Brieva J.A., Cordero V.A. [Validation of the Castillian version of the Hamilton Rating Scale for Depression]. Actas Luso Esp. Neurol. Psiquiatr. Cienc. Afines 1986, 14:324-334.
65. Rihmer A., Rozsa S., Rihmer Z., Gonda X., Akiskal K.K., Akiskal H.S. Affective temperaments, as measured by TEMPS-A, among nonviolent suicide attempters. J. Affect. Disord. 2009, 116:18-22.
66. Rihmer Z., Pestality P. Bipolar II disorder and suicidal behavior. Psychiatr. Clin. North Am. 1999, 22:667-673.
67. Romero S., Colom F., Iosif A.M., Cruz N., Pacchiarotti I., Sanchez-Moreno J., Vieta E. Relevance of family history of suicide in the long-term outcome of bipolar disorders. J. Clin. Psychiatry. 2007, 68:1517-1521.
68. Rosa A.R., Franco C., Martinez-Aran A., Sanchez-Moreno J., Salamero M., Valenti M., Tabares-Seisdedos R., Gonzalez-Pinto A., Kapczinski F., Vieta E. Functional impairment and previous suicide attempts in bipolar disorder. Acta Neuropsychiatrica 2008, 20:300-306.
69. Rowe M.K., Wiest C., Chuang D.M. GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder. Neurosci. Biobehav. Rev. 2007, 31:920-931.
70. Roy-Byrne P.P., Post R.M., Hambrick D.D., Leverich G.S., Rosoff A.S. Suicide and course of illness in major affective disorder. J. Affect. Disord. 1988, 15:1-8.
71. Ryu V., Jon D.I., Cho H.S., Kim S.J., Lee E., Kim E.J., Seok J.H. Initial depressive episodes affect the risk of suicide attempts in Korean patients with bipolar disorder. Yonsei Med. J. 2010, 51:641-647.
72. Sanchez-Gistau V., Colom F., Mane A., Romero S., Sugranyes G., Vieta E. Atypical depression is associated with suicide attempt in bipolar disorder. Acta Psychiatr. Scand. 2009, 120:30-36.
73. Sanders-Bush E. 5-HT receptors coupled to phosphoinositide hydrolysis. The Serotonin Receptors 1998, 181-198. Humana Press, NJ,USA. E. Sanders-Bush (Ed.).
74. Sequeira A., Mamdani F., Ernst C., Vawter M.P., Bunney W.E., Lebel V., Rehal S., Klempan T., Gratton A., Benkelfat C., Rouleau G.A., Mechawar N., Turecki G. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS ONE 2009, 4:e6585.
75. Serafini G., Pompili M., Innamorati M., Fusar-Poli P., Akiskal H.S., Rihmer Z., Lester D., Romano A., De O., I, Strusi L., Ferracuti S., Girardi P., Tatarelli R. Affective temperamental profiles are associated with white matter hyperintensity and suicidal risk in patients with mood disorders. J. Affect. Disord. 2011, 129:47-55.
76. Serretti A., Drago A., De R.D. Lithium pharmacodynamics and pharmacogenetics: focus on inositol mono phosphatase (IMPase), inositol poliphosphatase (IPPase) and glycogen sinthase kinase 3 beta (GSK-3 beta). Curr. Med. Chem. 2009, 16:1917-1948.
77. Sjoholt G., Ebstein R.P., Lie R.T., Berle J.O., Mallet J., Deleuze J.F., Levinson D.F., Laurent C., Mujahed M., Bannoura I., Murad I., Molven A., Steen V.M. Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder. Mol. Psychiatry. 2004, 9:621-629.
78. Sjoholt G., Molven A., Lovlie R., Wilcox A., Sikela J.M., Steen V.M. Genomic structure and chromosomal localization of a human myo-inositol monophosphatase gene (IMPA). Genomics 1997, 45:113-122.
79. Slama F., Bellivier F., Henry C., Rousseva A., Etain B., Rouillon F., Leboyer M. Bipolar patients with suicidal behavior: toward the identification of a clinical subgroup. J. Clin. Psychiatry. 2004, 65:1035-1039.
80. Steen V.M., Lovlie R., Osher Y., Belmaker R.H., Berle J.O., Gulbrandsen A.K. The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness. Pharmacogenetics 1998, 8:259-268.
81. Stockmeier C.A. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J. Psychiatr. Res. 2003, 37:357-373.
82. Swann A.C., Dougherty D.M., Pazzaglia P.J., Pham M., Steinberg J.L., Moeller F.G. Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder. Am. J. Psychiatry 2005, 162:1680-1687.
83. Tsai S.Y., Lee J.C., Chen C.C. Characteristics and psychosocial problems of patients with bipolar disorder at high risk for suicide attempt. J. Affect. Disord. 1999, 52:145-152.
84. Valtonen H., Suominen K., Mantere O., Leppamaki S., Arvilommi P., Isometsa E.T. Suicidal ideation and attempts in bipolar I and II disorders. J. Clin. Psychiatry 2005, 66:1456-1462.
85. Vieta E. Bipolar units and programmes: are they really needed?. World Psychiatry 2011, 10:152.
86. Vieta E. Tertiarism in Psychiatry: The Barcelona "Clinic" Bipolar Disorders Programme. Rev. Psiquiatr. Salud Ment. (Barc.) 2011, 4:1-4.
87. Vieta E., Colom F., Martinez-Aran A., Benabarre A., Gasto C. Personality disorders in bipolar II patients. J. Nerv. Ment. Dis. 1999, 187:245-248.
88. Vieta E., Colom F., Martinez-Aran A., Benabarre A., Reinares M., Gasto C. Bipolar II disorder and comorbidity. Compr. Psychiatry 2000, 41:339-343.
89. Vincze I., Perroud N., Buresi C., Baud P., Bellivier F., Etain B., Fournier C., Karege F., Matthey M.L., Preisig M., Leboyer M., Malafosse A. Association between brain-derived neurotrophic factor gene and a severe form of bipolar disorder, but no interaction with the serotonin transporter gene. Bipolar Disord. 2008, 10:580-587.
90. World Health Organization, 2008. The Global Burden of Disease: 2004 update. WHO Press. Ref Type: Report.
91. Yoon H.K., Kim Y.K. Association between glycogen synthase kinase-3beta gene polymorphisms and major depression and suicidal behavior in a Korean population. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:331-334.
92. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 1978, 133:429-435.